JSM · As filed with the SEC
Navient cash flow statement, by quarter
The statement as Navient presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows (Unaudited) · USD
| USD | Q2 2026 3 months ended Jun 30, 2026 | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 |
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net income | — | 17,000,000 | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Goodwill and acquired intangible asset impairment and amortization expense | — | 4,000,000 | — | — |
| Stock-based compensation expense | — | 3,000,000 | — | — |
| Mark-to-market (gains) losses on derivative and hedging activities, net | — | (14,000,000) | — | — |
| Provisions for loan losses | — | 27,000,000 | — | — |
| Decrease in accrued interest receivable | — | 38,000,000 | — | — |
| Increase (decrease) in accrued interest payable | — | (42,000,000) | — | — |
| Decrease (increase) in other assets | — | (51,000,000) | — | — |
| (Decrease) in other liabilities | — | (29,000,000) | — | — |
| Total adjustments | — | (64,000,000) | — | — |
| Net cash provided by operating activities | — | (47,000,000) | — | — |
| Cash flows from investing activities | ||||
| Education loans originated and acquired | — | (947,000,000) | — | — |
| Proceeds from payments on education loans | — | 1,622,000,000 | — | — |
| Other investing activities, net | — | 16,000,000 | — | — |
| Disposal of subsidiaries, net of cash and restricted cash disposed of | — | 0 | — | — |
| Net cash provided by investing activities | — | 691,000,000 | — | — |
| Cash flows from financing activities | ||||
| Borrowings collateralized by loans in trust - issued | — | 680,000,000 | — | — |
| Borrowings collateralized by loans in trust - repaid | — | (1,456,000,000) | — | — |
| Asset-backed Securities, Securitized Loans and Receivables | — | 192,000,000 | — | — |
| Long-term unsecured notes repaid | — | 0 | — | — |
| Other financing activities, net | — | 5,000,000 | — | — |
| Common stock repurchased | — | (23,000,000) | — | — |
| Common dividends paid | — | (15,000,000) | — | — |
| Net cash used in financing activities | — | (617,000,000) | — | — |
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | — | 27,000,000 | — | — |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 2,131,000,000 | 2,104,000,000 | 1,872,000,000 | 2,077,000,000 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 2,139,000,000 | 2,131,000,000 | 2,104,000,000 | 1,872,000,000 |
| Supplemental disclosure of cash flow information: | ||||
| Interest paid | — | 591,000,000 | — | — |
| Income taxes paid | — | 1,000,000 | — | — |
| Income taxes refunded | — | (1,000,000) | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.